Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of Intralesional and Perilesional Human Recombinant Epidermal Growth Factor (hrEGF) in the Local Treatment of Venous Ulcer - Review Article - Expert Recommendation.
Cacua Sanchez MT, Vargas Abello LM, Orrego Á, Ortiz P, Segura H, Berrio Caicedo JJ, Zuluaga LM, Ordoñez J, Fernández Montequin JI, Ulloa J. Cacua Sanchez MT, et al. Among authors: fernandez montequin ji. Vasc Health Risk Manag. 2023 Sep 7;19:595-603. doi: 10.2147/VHRM.S417447. eCollection 2023. Vasc Health Risk Manag. 2023. PMID: 37701155 Free PMC article. Review.
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.
Fernández-Montequín JI, Valenzuela-Silva CM, Díaz OG, Savigne W, Sancho-Soutelo N, Rivero-Fernández F, Sánchez-Penton P, Morejón-Vega L, Artaza-Sanz H, García-Herrera A, González-Benavides C, Hernández-Cañete CM, Vázquez-Proenza A, Berlanga-Acosta J, López-Saura PA; Cuban Diabetic Foot Study Group. Fernández-Montequín JI, et al. Int Wound J. 2009 Dec;6(6):432-43. doi: 10.1111/j.1742-481X.2009.00641.x. Int Wound J. 2009. PMID: 20051095 Free PMC article. Clinical Trial.
Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome.
Berlanga-Acosta J, Fernández-Montequín J, Valdés-Pérez C, Savigne-Gutiérrez W, Mendoza-Marí Y, García-Ojalvo A, Falcón-Cama V, García Del Barco-Herrera D, Fernández-Mayola M, Pérez-Saad H, Pimentel-Vázquez E, Urquiza-Rodríguez A, Kulikovsky M, Guillén-Nieto G. Berlanga-Acosta J, et al. Biomed Res Int. 2017;2017:2923759. doi: 10.1155/2017/2923759. Epub 2017 Aug 21. Biomed Res Int. 2017. PMID: 28904951 Free PMC article. Review.
Granulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor.
Valenzuela-Silva CM, Tuero-Iglesias ÁD, García-Iglesias E, González-Díaz O, Del Río-Martín A, Yera Alos IB, Fernández-Montequín JI, López-Saura PA. Valenzuela-Silva CM, et al. Among authors: fernandez montequin ji. Diabetes Care. 2013 Feb;36(2):210-5. doi: 10.2337/dc12-1323. Epub 2012 Sep 10. Diabetes Care. 2013. PMID: 22966096 Free PMC article. Clinical Trial.
Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.
Fernández-Montequín JI, Betancourt BY, Leyva-Gonzalez G, Mola EL, Galán-Naranjo K, Ramírez-Navas M, Bermúdez-Rojas S, Rosales F, García-Iglesias E, Berlanga-Acosta J, Silva-Rodriguez R, Garcia-Siverio M, Martinez LH. Fernández-Montequín JI, et al. Int Wound J. 2009 Feb;6(1):67-72. doi: 10.1111/j.1742-481X.2008.00561.x. Int Wound J. 2009. PMID: 19291119 Free PMC article. Clinical Trial.
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
Fernández-Montequín JI, Infante-Cristiá E, Valenzuela-Silva C, Franco-Pérez N, Savigne-Gutierrez W, Artaza-Sanz H, Morejón-Vega L, González-Benavides C, Eliseo-Musenden O, García-Iglesias E, Berlanga-Acosta J, Silva-Rodríguez R, Betancourt BY, López-Saura PA; Cuban Citoprot-P Study Group. Fernández-Montequín JI, et al. Int Wound J. 2007 Dec;4(4):333-43. doi: 10.1111/j.1742-481X.2007.00344.x. Epub 2007 Oct 22. Int Wound J. 2007. PMID: 17953679 Free PMC article. Clinical Trial.
Therapeutic efficacy of ozone in patients with diabetic foot.
Martínez-Sánchez G, Al-Dalain SM, Menéndez S, Re L, Giuliani A, Candelario-Jalil E, Alvarez H, Fernández-Montequín JI, León OS. Martínez-Sánchez G, et al. Among authors: fernandez montequin ji. Eur J Pharmacol. 2005 Oct 31;523(1-3):151-61. doi: 10.1016/j.ejphar.2005.08.020. Epub 2005 Sep 29. Eur J Pharmacol. 2005. PMID: 16198334 Clinical Trial.
15 results